579 related articles for article (PubMed ID: 28254221)
1. Progesterone/estradiol ratio <0.25 on the day of human chorionic gonadotropin administration is associated with adverse pregnancy outcomes in prolonged protocols for in vitro fertilization/intracytoplasmic sperm injection.
Li Y; Luo K; Tang Y; Lin G; Lu G; Gong F
Taiwan J Obstet Gynecol; 2017 Feb; 56(1):27-31. PubMed ID: 28254221
[TBL] [Abstract][Full Text] [Related]
2. The impact of LH, E2, and P level of HCG administration day on outcomes of in vitro fertilization in controlled ovarian hyperstimulation.
Wei M; Zhang XM; Gu FL; Lv F; Ji YR; Liu KF; She H; Hu R
Clin Exp Obstet Gynecol; 2015; 42(3):361-6. PubMed ID: 26152012
[TBL] [Abstract][Full Text] [Related]
3. The comparison of microdose flare-up and multiple dose antagonist protocols based on hCG day estradiol (E2), progesterone (P) and P/E2 ratio among poor responder patients in ICSI-ET cycles.
Cicek MN; Kahyaoglu I; Kahyaoglu S
Eur Rev Med Pharmacol Sci; 2015 Feb; 19(4):539-44. PubMed ID: 25753867
[TBL] [Abstract][Full Text] [Related]
4. Effect of progesterone/estradiol ratio on pregnancy outcome of patients with high trigger-day progesterone levels undergoing gonadotropin-releasing hormone antagonist intracytoplasmic sperm injection cycles: a retrospective cohort study.
Golbasi H; Ince O; Golbasi C; Ozer M; Demir M; Yilmaz B
J Obstet Gynaecol; 2019 Feb; 39(2):157-163. PubMed ID: 30280612
[TBL] [Abstract][Full Text] [Related]
5. The impact of an increased progesterone-to-follicle number ratio on live delivery rates in women with normal ovarian reserve.
Chen Y; Ma L; Wang S
Int J Gynaecol Obstet; 2017 Oct; 139(1):84-89. PubMed ID: 28685817
[TBL] [Abstract][Full Text] [Related]
6. Serum progesterone level effects on the outcome of in vitro fertilization in patients with different ovarian response: an analysis of more than 10,000 cycles.
Xu B; Li Z; Zhang H; Jin L; Li Y; Ai J; Zhu G
Fertil Steril; 2012 Jun; 97(6):1321-7.e1-4. PubMed ID: 22494924
[TBL] [Abstract][Full Text] [Related]
7. Effect of HCG-day serum progesterone and oestradiol concentrations on pregnancy outcomes in GnRH agonist cycles.
Wu Z; Li R; Ma Y; Deng B; Zhang X; Meng Y; Chen X; Liu P; Qiao J
Reprod Biomed Online; 2012 May; 24(5):511-20. PubMed ID: 22417667
[TBL] [Abstract][Full Text] [Related]
8. Serum estradiol level change after human chorionic gonadotropin administration had no correlation with live birth rate in IVF cycles.
Huang R; Fang C; Wang N; Li L; Yi Y; Liang X
Eur J Obstet Gynecol Reprod Biol; 2014 Jul; 178():177-82. PubMed ID: 24862918
[TBL] [Abstract][Full Text] [Related]
9. Timing of human chorionic gonadotropin (hCG) hormone administration in IVF/ICSI protocols using GnRH agonist or antagonists: a systematic review and meta-analysis.
Chen Y; Zhang Y; Hu M; Liu X; Qi H
Gynecol Endocrinol; 2014 Jun; 30(6):431-7. PubMed ID: 24731070
[TBL] [Abstract][Full Text] [Related]
10. Impact of progesterone (on hCG day)/oocyte ratio on pregnancy outcome in long agonist non donor fresh IVF/ICSI cycles.
Singh N; Malik N; Malhotra N; Vanamail P; Gupta M
Taiwan J Obstet Gynecol; 2016 Aug; 55(4):503-6. PubMed ID: 27590371
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the effects of three luteal phase support protocols with estrogen on in vitro fertilization-embryo transfer outcomes in patients on a GnRH antagonist protocol.
Scheffer JB; Scheffer BB; Carvalho RF; Aguiar AP; Lozano DHM; Labrosse J; Grynberg M
JBRA Assist Reprod; 2019 Aug; 23(3):239-245. PubMed ID: 30875186
[TBL] [Abstract][Full Text] [Related]
12. Addition of low-dose hCG to rFSH during ovarian stimulation for IVF/ICSI: is it beneficial?
Partsinevelos GA; Antonakopoulos N; Kallianidis K; Drakakis P; Anagnostou E; Bletsa R; Loutradis D
Clin Exp Obstet Gynecol; 2016; 43(6):818-825. PubMed ID: 29944230
[TBL] [Abstract][Full Text] [Related]
13. Premature Progesterone Elevation Does Not Affect Pregnancy Outcome in High-Responder Patients Undergoing Short-Interval Coasting in IVF Cycles.
Acet M; Aktün LH; Başaranoğlu S; Yorgunlar B; Acet T; Deregözü A
Med Sci Monit Basic Res; 2015 Nov; 21():247-52. PubMed ID: 26634938
[TBL] [Abstract][Full Text] [Related]
14. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
[TBL] [Abstract][Full Text] [Related]
15. Exploration of the value of progesterone and progesterone/estradiol ratio on the hCG trigger day in predicting pregnancy outcomes of PCOS patients undergoing IVF/ICSI: a retrospective cohort study.
Yang Y; Liu B; Wu G; Yang J
Reprod Biol Endocrinol; 2021 Dec; 19(1):184. PubMed ID: 34893087
[TBL] [Abstract][Full Text] [Related]
16. Influence of Different Gonadotropin-releasing Hormone Agonist Administration Methods on Pregnancy Outcomes of Patients Undergoing In-vitro Fertilization-embryo Transfer.
Wu L; Ren XL; Chen W; Huang B; Zhou YF; Jin L
Curr Med Sci; 2019 Jun; 39(3):437-441. PubMed ID: 31209816
[TBL] [Abstract][Full Text] [Related]
17. Should progesterone on the human chorionic gonadotropin day still be measured?
Martinez F; Rodriguez I; Devesa M; Buxaderas R; Gómez MJ; Coroleu B
Fertil Steril; 2016 Jan; 105(1):86-92. PubMed ID: 26453983
[TBL] [Abstract][Full Text] [Related]
18. 1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study.
Humaidan P; Ejdrup Bredkjaer H; Westergaard LG; Yding Andersen C
Fertil Steril; 2010 Feb; 93(3):847-54. PubMed ID: 19200959
[TBL] [Abstract][Full Text] [Related]
19. The duration of pre-ovulatory serum progesterone elevation before hCG administration affects the outcome of IVF/ICSI cycles.
Huang CC; Lien YR; Chen HF; Chen MJ; Shieh CJ; Yao YL; Chang CH; Chen SU; Yang YS
Hum Reprod; 2012 Jul; 27(7):2036-45. PubMed ID: 22561057
[TBL] [Abstract][Full Text] [Related]
20. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.
Lin MH; Wu FS; Lee RK; Li SH; Lin SY; Hwu YM
Fertil Steril; 2013 Nov; 100(5):1296-302. PubMed ID: 23993928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
